Tag: NAMPT

NAD⁺ Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications

This review article highlights the critical role of nicotinamide adenine dinucleotide (NAD⁺) deficiency in various diseases and aging processes. It discusses how NAD⁺ deficiency is observed in models of cerebral ischemia, myocardial ischemia, diabetes, and aging. The deficiency results from factors like poly(ADP-ribose) polymerase-1 (PARP-1) activation, decreased nicotinamide phosphoribosyltransferase (Nampt)

Read More »

NAD+ in Aging: Molecular Mechanisms and Translational Implications

This 2017 review explores the critical role of nicotinamide adenine dinucleotide (NAD⁺) in aging and age-related diseases. NAD⁺ is essential for cellular metabolism, DNA repair, and stress responses. The study highlights that NAD⁺ levels decline with age, contributing to various pathologies, including neurodegenerative diseases, cardiovascular conditions, and muscle atrophy. The

Read More »

Impaired Nicotinamide Adenine Dinucleotide (NAD⁺) Metabolism in Diabetes and Diabetic Tissues: Implications for Nicotinamide-Related Compound Treatment

This 2020 review explores how diabetes disrupts NAD⁺ metabolism, leading to reduced NAD⁺/NADH ratios (pseudohypoxia) due to increased substrate oxidation. In type 1 diabetes, NAD⁺ depletion is driven by poly(ADP-ribose) polymerase (PARP) activation, while in type 2 diabetes, decreased AMP-activated protein kinase (AMPK) activity impairs NAD⁺ biosynthesis via downregulation of

Read More »